Cutaneous reactions to drugs
暂无分享,去创建一个
D. Creamer | S. Walsh | H. Lee
[1] Zackery Bullard,et al. Warfarin-Induced Skin Necrosis , 2014, Hospital pharmacy.
[2] D. Creamer,et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking , 2011, Clinical and experimental dermatology.
[3] G. Piérard,et al. New Insights in Toxic Epidermal Necrolysis (Lyell’s Syndrome) , 2010, Drug safety.
[4] B. K. Park,et al. Food , drug , insect sting allergy , and anaphylaxis Stimulation of human T cells with sulfonamides and sulfonamide metabolites , 2022 .
[5] P. Brennan,et al. Food , drug , insect sting allergy , and anaphylaxis Hypersensitivity reactions to mAbs : 105 desensitizations in 23 patients , from evaluation to treatment , 2011 .
[6] A. Marzano,et al. Drug-induced lupus: an update on its dermatologic aspects , 2009, Lupus.
[7] S. Calvieri,et al. Amoxicillin–clavulanic acid‐induced linear immunoglobulin A bullous dermatosis: case report and review of the literature , 2009, International journal of dermatology.
[8] S. Tiamkao,et al. Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population , 2009, Pharmacogenetics and genomics.
[9] A. Gottlieb,et al. Dermatological complications and safety of anti-TNF treatments , 2009, Gut.
[10] A. Gottlieb,et al. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. , 2009, Journal of the American Academy of Dermatology.
[11] E. Guevara-Gutiérrez,et al. Acute generalized exanthematous pustulosis: report of 12 cases and literature review , 2009, International journal of dermatology.
[12] M. Mockenhaupt. Severe drug‐induced skin reactions: clinical pattern, diagnostics and therapy , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[13] T. Kuo,et al. Clinicopathlogical features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.
[14] H. Justiniano,et al. Pattern Analysis of Drug-Induced Skin Diseases , 2008, The American Journal of dermatopathology.
[15] E. Phillips,et al. A review of drug patch testing and implications for HIV clinicians , 2008, AIDS.
[16] A. Segal,et al. Cutaneous Reactions to Drugs in Children , 2007, Pediatrics.
[17] H. Uchi,et al. Stevens-Johnson Syndrome, Drug-Induced Hypersensitivity Syndrome and Toxic Epidermal Necrolysis Caused by Allopurinol in Patients with a Common HLA Allele: What Causes the Diversity? , 2007, Dermatology.
[18] J. Albrecht,et al. Drug-associated lymphoma and pseudolymphoma: recognition and management. , 2007, Dermatologic clinics.
[19] E. Cowen. Epidermal growth factor receptor inhibitors: a new era of drug reactions in a new era of cancer therapy. , 2007, Journal of the American Academy of Dermatology.
[20] S. Helfgott,et al. Serum sickness following treatment with rituximab. , 2007, The Journal of rheumatology.
[21] J. Tolland,et al. Voriconazole‐induced pseudoporphyria , 2007, Photodermatology, photoimmunology & photomedicine.
[22] A. Bircher,et al. Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options , 2006, Allergy.
[23] M. Tohyama,et al. Reactivation of human herpesvirus (HHV) family members other than HHV‐6 in drug‐induced hypersensitivity syndrome , 2006, The British journal of dermatology.
[24] S. Jee,et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions , 2006, Pharmacogenetics and genomics.
[25] A. Barbaud. Drug patch testing in systemic cutaneous drug allergy. , 2005, Toxicology.
[26] N. Scheinfeld. Impact of phenytoin therapy on the skin and skin disease , 2004, Expert opinion on drug safety.
[27] M. Britschgi,et al. Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells , 2002, Current opinion in allergy and clinical immunology.
[28] A. Gaspari,et al. Nonsteroidal Antiinflammatory Drug-Induced Pseudoporphyria: A Case Series , 2002, Journal of cutaneous medicine and surgery.
[29] M. Gonçalo,et al. Guidelines for performing skin tests withdrugs in the investigation of cutaneous adverse drug reactions , 2001, Contact dermatitis.
[30] M. Bigby. Rates of cutaneous reactions to drugs. , 2001, Archives of dermatology.
[31] N. Shear,et al. A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes. , 2000, Clinical biochemistry.
[32] J. Uetrecht,et al. Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions? , 2000, Current drug metabolism.
[33] C. González‐Herrada,et al. Treatment of toxic epidermal necrolysis with cyclosporin A. , 2000, The Journal of trauma.
[34] R. Patterson,et al. Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases. , 2000, Allergy and asthma proceedings.
[35] C. Lovell,et al. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline‐induced lupus‐like syndrome , 2000, The British journal of dermatology.
[36] N. Shear,et al. What are some of the lessons learnt from in vitro studies of severe unpredictable drug reactions? , 2000, The British journal of dermatology.
[37] K. Pramatarov. Drug-induced lupus erythematosus. , 1998, Clinics in dermatology.
[38] G. Kearns,et al. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility. , 1994, The Journal of pediatrics.
[39] W. Bergfeld,et al. Amiodarone-induced linear IgA disease. , 1994, Journal of the American Academy of Dermatology.
[40] B. Lang,et al. Naproxen-induced pseudoporphyria in patients with juvenile rheumatoid arthritis. , 1994, The Journal of pediatrics.
[41] S. Halevy,et al. Lichenoid drug eruptions. , 1993, Journal of the American Academy of Dermatology.
[42] M. Rieder,et al. Drug‐induced hypothyroidism: The thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides , 1992, Clinical pharmacology and therapeutics.
[43] V. Ruocco,et al. Pemphigus and Bullous Pemphigoid due to Drugs , 1991, International journal of dermatology.
[44] S. Spielberg,et al. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. , 1988, The Journal of clinical investigation.
[45] C. Dollery,et al. HYDRALAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS: INFLUENCE OF HLA-DR AND SEX ON SUSCEPTIBILITY , 1980, The Lancet.
[46] V. Tozzi. Pharmacogenetics of antiretrovirals. , 2010, Antiviral research.
[47] E. Ozkaya. Fixed drug eruption: state of the art. , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[48] M. Mockenhaupt,et al. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study. , 2008, Journal of the American Academy of Dermatology.
[49] J. Roujeau,et al. Drug-Induced Skin, Nail and Hair Disorders , 2007, Drug safety.
[50] T. F. Downham,et al. Furosemide-induced bullous pemphigoid: case report and review of literature. , 2006, Journal of drugs in dermatology : JDD.
[51] L. Maas,et al. Serum sickness-like reactions in patients receiving intravenous infliximab. , 2006, The Journal of emergency medicine.
[52] S. Knowles,et al. Should Celecoxib Be Contraindicated in Patients Who Are Allergic to Sulfonamides? , 2001, Drug safety.
[53] B. Pomeranz,et al. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. , 1998, JAMA.
[54] F. Klopp. Guidelines of care for cutaneous adverse drug reactions , 1996 .
[55] F. Dove. Drug-induced lupus , 1982 .
[56] M. Blaiss,et al. Drug allergy. , 1988, Pediatric clinics of North America.
[57] W. Falk,et al. Successful treatment of lithium-induced acne. , 1986, Journal of Clinical Psychiatry.
[58] J. Gõmez Orbaneja,et al. [Toxic epidermal necrolysis]. , 1967, Revista clinica espanola.